1. Home
  2. PBYI vs LESL Comparison

PBYI vs LESL Comparison

Compare PBYI & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • LESL
  • Stock Information
  • Founded
  • PBYI 2010
  • LESL 1963
  • Country
  • PBYI United States
  • LESL United States
  • Employees
  • PBYI N/A
  • LESL N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • LESL Diversified Commercial Services
  • Sector
  • PBYI Health Care
  • LESL Miscellaneous
  • Exchange
  • PBYI Nasdaq
  • LESL Nasdaq
  • Market Cap
  • PBYI 138.4M
  • LESL 116.5M
  • IPO Year
  • PBYI N/A
  • LESL 2020
  • Fundamental
  • Price
  • PBYI $2.91
  • LESL $0.73
  • Analyst Decision
  • PBYI Strong Buy
  • LESL Hold
  • Analyst Count
  • PBYI 1
  • LESL 11
  • Target Price
  • PBYI $7.00
  • LESL $2.32
  • AVG Volume (30 Days)
  • PBYI 280.0K
  • LESL 2.3M
  • Earning Date
  • PBYI 05-08-2025
  • LESL 05-08-2025
  • Dividend Yield
  • PBYI N/A
  • LESL N/A
  • EPS Growth
  • PBYI 143.51
  • LESL N/A
  • EPS
  • PBYI 0.77
  • LESL N/A
  • Revenue
  • PBYI $232,668,000.00
  • LESL $1,319,859,000.00
  • Revenue This Year
  • PBYI N/A
  • LESL $2.77
  • Revenue Next Year
  • PBYI N/A
  • LESL $2.93
  • P/E Ratio
  • PBYI $3.78
  • LESL N/A
  • Revenue Growth
  • PBYI 2.67
  • LESL N/A
  • 52 Week Low
  • PBYI $2.23
  • LESL $0.51
  • 52 Week High
  • PBYI $5.20
  • LESL $6.02
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 44.50
  • LESL 56.70
  • Support Level
  • PBYI $2.88
  • LESL $0.64
  • Resistance Level
  • PBYI $3.14
  • LESL $0.73
  • Average True Range (ATR)
  • PBYI 0.16
  • LESL 0.05
  • MACD
  • PBYI 0.00
  • LESL 0.03
  • Stochastic Oscillator
  • PBYI 11.36
  • LESL 94.11

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.

Share on Social Networks: